Mirae Asset Global ETFs Holdings
TRDA icon

Mirae Asset Global ETFs Holdings’s Entrada Therapeutics TRDA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio TRDA Stock Details TRDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$171K Buy
13,577
+329
+2% +$3.77K ﹤0.01% 2436
2025
Q4 		$136K Buy
13,248
+140
+1% +$1.18K ﹤0.01% 2534
2025
Q3 		$76K Sell
13,108
-2,280
-15% -$13.3K ﹤0.01% 2793
2025
Q2 		$103K Buy
15,388
+589
+4% +$4.74K ﹤0.01% 2598
2025
Q1 		$134K Buy
14,799
+624
+4% +$7.78K ﹤0.01% 2498
2024
Q4 		$245K Buy
14,175
+608
+4% +$11K ﹤0.01% 2281
2024
Q3 		$217K Buy
13,567
+2,178
+19% +$34.3K ﹤0.01% 2341
2024
Q2 		$162K Buy
+11,389
New +$162K ﹤0.01% 2362

Other funds holding TRDA

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return